MassDevice.com +5 | The top 5 medtech stories for April 13, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Toshiba partners with UCI to study potential brain damage in HS football players Toshiba said yesterday it is partnering with the University of California, Irvine to study possible brain damage incurred in high school football players. The study is the 1st-of-its-kind investigating cerebral microbleeds as a potential precursor to chronic traumatic encephalopathy, and will operate using Toshiba’s Vantage Titan 3T magnetic resonance imager as the main diagnostic tool, the company said. Read more 4. Medtronic touts insulin pump study Patients with Type II diabetes fared better with Medtronic’s MiniMed Paradigm Veo insulin pumps that with multiple daily injections, according to a Medtronic-backed study published in the journal Diabetes, Obesity & Metabolism. Fridley, Minn.-based Medtronic said the 331-patient Opt2mise clinical trial compared the MDI cohort with the MiniMed-treated group; after 6 months, the MDI cohort was moved to the MiniMed arm; at 12 months, the group that moved to the insulin pump arm doubled the A1C measurement for glucose control and used...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news